Latest News - Intuitive Surgical
Top Corporates Hub
Intuitive Surgical
Does Billionaire Philippe Laffont Know Something Wall Street Doesn't? His Hedge Fund Is Backing a Stock That Jumped 211% in Just 5 Days.
29.10.2025 07:30
Philippe Laffont's hedge fund, Coatue Management, owns shares of Beyond Meat.
Intuitive Surgical’s Q3 Earnings Call: Our Top 5 Analyst Questions
28.10.2025 05:33
Intuitive Surgical's third quarter results were met with a strongly positive market reaction, as management credited robust demand for the da Vinci V system and expanded international placements as primary growth drivers. CEO David J. Rosa highlighted that widespread adoption of da Vinci V, along with higher procedure volumes in both U.S. and international markets, contributed to improved utilization rates across all platforms. Additionally, elevated interest in system upgrades and first placeme
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
27.10.2025 13:30
According to the average brokerage recommendation (ABR), one should invest in Intuitive Surgical (ISRG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
27.10.2025 13:00
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical vs. Medtronic: Which Stock Is the Better Buy?
27.10.2025 12:40
The long-awaited face-off between these two medical device giants is finally upon us.
Intuitive Surgical, Inc. 2025 Q3 - Results - Earnings Call Presentation
23.10.2025 02:00
2025-10-23. The following slide deck was published by Intuitive Surgical, Inc.
Intuitive Surgical (ISRG): Assessing Valuation as FDA Clears New AI Technology and Q3 Earnings Approach
21.10.2025 14:12
Investor enthusiasm is building for Intuitive Surgical as the company heads into its third-quarter earnings announcement. The spotlight is on recent FDA clearance of advanced AI-driven software for the Ion platform, which reinforces the firm's reputation for innovation. See our latest analysis for Intuitive Surgical. After a sharp pullback from its highs, Intuitive Surgical’s momentum appears to be turning the corner, with a 5.1% gain in the past week reflecting renewed confidence in the...
Will ISRG's dV5 Lend Momentum to Top Line During Q3 Earnings?
21.10.2025 12:58
Intuitive Surgical's new da Vinci 5 is driving strong hospital upgrades and premium pricing, setting up ISRG for potential top-line momentum in Q3.
Intuitive Surgical Earnings: What To Look For From ISRG
20.10.2025 03:06
Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be announcing earnings results this Tuesday afternoon. Here’s what to expect.
Should You Forget Intuitive Surgical and Buy This Magnificent Medical Device Stock Instead?
16.10.2025 08:25
Intuitive Surgical runs a great business, but it is a one-trick pony, which may make this surgical robot competitor a better choice for you.
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
14.10.2025 12:34
ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.
Intuitive Surgical Inc. (ISRG): Firm Releases Updates For da Vinci 5
09.10.2025 07:15
Intuitive Surgical Inc. (NASDAQ:ISRG) is one of the companies that are pertinent to the discussion about The Future of Artificial Intelligence: 10 Predictions for 10 Industries. In June this year, Larry Ellison, the billionaire co-founder of Oracle Corporation, said during the second quarter earnings call that Oracle Health was building AI agents into its EHR […]
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
08.10.2025 13:15
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures Intuitive expands AI and advanced imaging integration in Ion Endoluminal System Ion system during a procedure setup SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food & Drug Administration (FDA) has cleared software advance
Is Analyst Uncertainty and Insider Buying Shifting the Long-Term Narrative for Intuitive Surgical (ISRG)?
08.10.2025 05:11
In recent days, Intuitive Surgical has drawn investor attention following a series of analyst recommendation changes, downward earnings estimate revisions, and news of a significant stock purchase by Senator Markwayne Mullin in late September 2025. While the company remains a leader in the global robotic surgery market, a contrast between optimistic brokerage ratings and more cautious analyst revisions has introduced fresh uncertainty ahead of its anticipated earnings release. To understand...
Should You Buy Shares of Intuitive Surgical In October?
06.10.2025 08:20
The company dominates the high-growth market of surgical robots.
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
06.10.2025 04:36
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.
Meet the 3%-Yielding Dividend Stock That Could Soar in 2026
02.10.2025 12:00
The growth of surgical robots is huge, and this company is looking to get in on the action while it also works to boost its profit margin.
3 Reasons to Buy Intuitive Surgical Stock Near Its 52-Week Low
01.10.2025 10:00
This is by no means an exhaustive list.
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
29.09.2025 12:17
ISRG and ZBH both push robotics forward, but valuation and Zacks Rank tilt near-term upside toward Zimmer Biomet. Which one offers a better bet?
Bridge to Life Appoints David Castiglioni as Chief Commercial Officer to Head Global Commercial Operations and Lead the U.S. Commercialization of VitaSmart™
29.09.2025 10:00
Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, today announced the appointment of David Castiglioni as Chief Commercial Officer (CCO). In this role, Mr. Castiglioni will be responsible for all global commercial operations, with an immediate focus on preparing for the U.S. launch of the VitaSmart™ Hypothermic Oxygenated Perfusion System upon FDA clearance. The United States represents the largest global market for machine perfusion technology.